Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

Dyad Medical Echo:Prio FDA

Regulatory Roundup: FDA approves new-look self-expanding stent, clears 2 advanced AI models

The FDA has had a busy month, overseeing the recall of nearly 88,000 implantable cardiac devices, juggling the continued rise of monkeypox cases in the United States and maintaining an active Breakthrough Devices program. This rundown covers some of the agency's biggest moves during that time. 

Onyx Frontier drug-eluting stent Medtronic FDA approval CE mark approval

Medtronic launches updated drug-eluting coronary stent system

The news comes after the Onyx Frontier DES gained CE mark approval. It received FDA approval in May.

Jianyi "Jay" Zhang, MD, PhD, is leading research on growing new heart muscle cells

Researchers receive $11.2M to study how the heart recovers from significant damage

The National Heart, Lung and Blood Institute, part of the National Institutes of Health, awarded the funds to three research teams. 

Study the signs: The most common symptoms of 6 cardiovascular diseases

A new scientific statement details the most common symptoms associated with heart attacks, heart failure and other cardiac conditions. Importantly, the authors wrote, clinicians must remember that symptoms can vary between men and women. 

American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification

The new certification, based on recommendations published in Circulation, was developed to signal that a facility offers cardiac surgery and primary PCI at all times. 

Cardiovascular deaths are on the decline—but there is still a lot of work to do

Three recent NIH-supported studies took a close look at disparities in cardiovascular care.

cardiac scale bodyport fda clearance

Cardiac scale gains FDA clearance, putting patients 1 step away from a heart assessment

The newly cleared device works like a traditional scale, but it captures more data than just the user's weight. 

Thumbnail

Cardiologists sound the alarm as ‘staggering’ new data suggest CVD rates in the U.S. will rise dramatically

New data from the CDC and U.S. Census Bureau show just how bad CVD rates could get in the next few decades. Specialists agree that a lot of work is needed to help keep these estimates from becoming a reality.